In the AMBAR trial, six sessions of weekly TPE with albumin replacement in patients with mild-to-moderate AD were associated with stabilization of cognitive decline and attenuated brain atrophy (monitoring for one-year) [15]. Here, ALB is linked to Alzheimer disease.